Dunia

Li Ka-shing funds Asia’s first non-invasive kidney tumour trials in Hong Kong

South China Morning Post · 42 menit lalu

Sumber: South China Morning Post · 42 menit lalu

Recap • TITIR

Hong Kong to run Asia’s first non-invasive kidney tumour trials using histotripsy.
Li Ka-shing funds 30 patient spots across three private hospitals.
Trials at CUHK Medical Centre, Gleneagles Hospital Hong Kong, and Hong Kong Sanatorium & Hospital.
Histotripsy uses focused sound waves to break tumours without surgery.
Treatment targets kidney tumours without surgical incisions.

Recap singkat dari artikel aslinya. Bisa aja kurang pas — baca sumber aslinya buat versi lengkap.